Transcranial direct current stimulation is safe and effective in autoimmune myopathies: a randomised, double-blind, sham-controlled trial

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSOUSA, L. F. A. de
dc.contributor.authorMISSE, R. G.
dc.contributor.authorSANTOS, L. M. dos
dc.contributor.authorTANAKA, C.
dc.contributor.authorGREVE, J. M. A.
dc.contributor.authorBAPTISTA, A. F.
dc.contributor.authorSHINJO, S. K.
dc.date.accessioned2023-06-21T14:08:01Z
dc.date.available2023-06-21T14:08:01Z
dc.date.issued2023
dc.description.abstractObjective We aimed to assess the safety and efficacy of transcranial direct current stimulation (tDCS) in patients with systemic autoimmune myopathies (SAMs).Methods This prospective, randomised, sham-controlled, double-blind, study included 20 patients with SAMs allocated to receive sham or active tDCS (2mA, 20 minutes, 3 days). Electrodes were positioned with the anode over the C1 or C2, whereas the cathode was placed over the Fp2 or Fp1, respectively. The groups were evaluated in four periods with specific questionnaires and functional tests: pre-stimulation and after 30 minutes, three weeks, and eight weeks post-tDCS.Results Two patients from the sham group withdrew after the three sessions. The demographic data, type of myositis, disease duration, and disease status were comparable between the active and sham tDCS groups. After interventions, in the active tDCS group, the physical aspects of SF-36 in week eight, mean and better timed up-and-go test at each evaluation, peak torque of stimulated inferior limb extension improved significantly (p<0.05). The emotional aspect of SF-36 decreased only in the active tDCS group (p<0.001). The patients' adherence to the protocol was 100% and no serious adverse event was reported, including disease relapses.Conclusion This study evidences the safety of tDCS, as well as its potential efficacy in improving muscle strength and function in SAMs patients. More studies with a larger sample and longer tDCS sessions are necessary to corroborate the results of the present study.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2019/12155-5, 2019/11776-6]
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [303379/2018-9]
dc.description.sponsorshipFaculdade de Medicina da USP
dc.identifier.citationCLINICAL AND EXPERIMENTAL RHEUMATOLOGY, v.41, n.2, p.221-229, 2023
dc.identifier.eissn1593-098X
dc.identifier.issn0392-856X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/53894
dc.language.isoeng
dc.publisherCLINICAL & EXPER RHEUMATOLOGYeng
dc.relation.ispartofClinical and Experimental Rheumatology
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright CLINICAL & EXPER RHEUMATOLOGYeng
dc.subjectinflammatory myopathieseng
dc.subjectmyositiseng
dc.subjectneuromodulationeng
dc.subjectsafetyeng
dc.subjectquality of lifeeng
dc.subject.otheridiopathic inflammatory myopathieseng
dc.subject.otheroutcome assessmenteng
dc.subject.otheranodal-tdcseng
dc.subject.otheradulteng
dc.subject.otherclassificationeng
dc.subject.otherguidelineseng
dc.subject.otherfatigueeng
dc.subject.otherupdateeng
dc.subject.wosRheumatologyeng
dc.titleTranscranial direct current stimulation is safe and effective in autoimmune myopathies: a randomised, double-blind, sham-controlled trialeng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.contributor.author-fmusphcLUIZ FELIPE ADSUARA DE SOUSA
hcfmusp.contributor.author-fmusphcRAFAEL GIOVANE MISSE
hcfmusp.contributor.author-fmusphcLUCAS DE MACEDO DOS SANTOS
hcfmusp.contributor.author-fmusphcCLARICE TANAKA
hcfmusp.contributor.author-fmusphcJULIA MARIA D ANDREA GREVE
hcfmusp.contributor.author-fmusphcABRAHAO FONTES BAPTISTA
hcfmusp.contributor.author-fmusphcSAMUEL KATSUYUKI SHINJO
hcfmusp.description.beginpage221
hcfmusp.description.endpage229
hcfmusp.description.issue2
hcfmusp.description.volume41
hcfmusp.origemWOS
hcfmusp.origem.pubmed35383556
hcfmusp.origem.wosWOS:000952863200006
hcfmusp.publisher.cityPISAeng
hcfmusp.publisher.countryITALYeng
hcfmusp.relation.referenceAllenbach Y, 2018, NEUROMUSCULAR DISORD, V28, P87, DOI 10.1016/j.nmd.2017.09.016eng
hcfmusp.relation.reference[Anonymous], 2012, 10 20 SYSTEM POSITIOeng
hcfmusp.relation.referenceAtzeni F, 2011, BEST PRACT RES CL RH, V25, P165, DOI 10.1016/j.berh.2010.01.011eng
hcfmusp.relation.referenceBikson M, 2016, BRAIN STIMUL, V9, P641, DOI 10.1016/j.brs.2016.06.004eng
hcfmusp.relation.referencede Souza FHC, 2019, ADV RHEUMATOL, V59, DOI 10.1186/s42358-019-0048-xeng
hcfmusp.relation.referencede Souza FHC, 2012, REV BRAS REUMATOL, V52, P892eng
hcfmusp.relation.referenceCarter MJ, 2017, BRAIN STIMUL, V10, P162, DOI 10.1016/j.brs.2016.11.002eng
hcfmusp.relation.referenceCavagna L, 2019, J CLIN MED, V8, DOI 10.3390/jcm8112013eng
hcfmusp.relation.referenceCavagna L, 2018, ANN RHEUM DIS, V77, DOI 10.1136/annrheumdis-2017-212368eng
hcfmusp.relation.referenceCiconelli RM, 1999, REV BRAS REUMATOL, V39, P143, DOI 10.1590/S0482-50042010000300005eng
hcfmusp.relation.referenceClark BC, 2021, J GERONTOL A-BIOL, V76, P1882, DOI 10.1093/gerona/glab098eng
hcfmusp.relation.referenceClark BC, 2014, J NEUROPHYSIOL, V112, P3219, DOI 10.1152/jn.00386.2014eng
hcfmusp.relation.referencede Oliveira DS, 2018, ADV RHEUMATOL, V58, DOI 10.1186/s42358-018-0004-1eng
hcfmusp.relation.referenceEKDAHL C, 1988, SCAND J RHEUMATOL, V17, P263, DOI 10.3109/03009748809098795eng
hcfmusp.relation.referenceFerreira G, 2020, J DIABETES METAB DIS, V19, P327, DOI 10.1007/s40200-020-00513-4eng
hcfmusp.relation.referenceGandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003eng
hcfmusp.relation.referenceHadoush H, 2018, MED SCI MONIT BASIC, V24, P198, DOI 10.12659/MSMBR.911411eng
hcfmusp.relation.referenceIlic NV, 2016, RESTOR NEUROL NEUROS, V34, P935, DOI 10.3233/RNN-160668eng
hcfmusp.relation.referenceIsenberg DA, 2004, RHEUMATOLOGY, V43, P49, DOI 10.1093/rheumatology/keg427eng
hcfmusp.relation.referenceJales Junior Levi Higino, 2015, Rev. dor, V16, P37, DOI 10.5935/1806-0013.20150008eng
hcfmusp.relation.referenceJones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028eng
hcfmusp.relation.referenceKatz P, 2017, CURR OPIN RHEUMATOL, V29, P269, DOI 10.1097/BOR.0000000000000376eng
hcfmusp.relation.referenceLattari E, 2020, J STRENGTH COND RES, V34, P97, DOI 10.1519/JSC.0000000000001956eng
hcfmusp.relation.referenceLefaucheur JP, 2019, NEUROPHYSIOL CLIN, V49, P269, DOI 10.1016/j.neucli.2019.07.013eng
hcfmusp.relation.referenceLefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087eng
hcfmusp.relation.referenceLiu XY, 2019, BRAIN IMAGING BEHAV, V13, P1324, DOI 10.1007/s11682-018-9948-3eng
hcfmusp.relation.referenceLundberg IE, 2017, ANN RHEUM DIS, V76, P1955, DOI 10.1136/annrheumdis-2017-211468eng
hcfmusp.relation.referenceMachado DGD, 2019, BRAIN STIMUL, V12, P593, DOI 10.1016/j.brs.2018.12.227eng
hcfmusp.relation.referenceMachado S, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01127eng
hcfmusp.relation.referenceMagalhaes Sales M, 2016, MED SPORT, V69, P163eng
hcfmusp.relation.referenceMatsudo S., 2001, REV BRAS ATIV FIS SA, V6, P5, DOI 10.12820/RBAFS.V.6N2P5-18eng
hcfmusp.relation.referenceMcGrath ER, 2018, NEUROTHERAPEUTICS, V15, P976, DOI 10.1007/s13311-018-00676-2eng
hcfmusp.relation.referenceMendonca ME, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00068eng
hcfmusp.relation.referenceMiller FW, 2001, RHEUMATOLOGY, V40, P1262, DOI 10.1093/rheumatology/40.11.1262eng
hcfmusp.relation.referenceMISSE RG, 2020, OPEN J RHEUMATOL AUT, V10, P88eng
hcfmusp.relation.referenceMizuno T, 2017, NEUROSCI RES, V114, P55, DOI 10.1016/j.neures.2016.08.004eng
hcfmusp.relation.referenceMorya E, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0581-1eng
hcfmusp.relation.referenceOddis CV, 2005, ARTHRITIS RHEUM, V52, P2607, DOI 10.1002/art.21291eng
hcfmusp.relation.referenceOrru G, 2020, REV NEUROSCIENCE, V31, P201, DOI 10.1515/revneuro-2019-0047eng
hcfmusp.relation.referenceParma JO, 2021, J MOTOR BEHAV, V53, P431, DOI 10.1080/00222895.2020.1792823eng
hcfmusp.relation.referencePinto ACPN, 2021, BRAIN STIMUL, V14, P141, DOI 10.1016/j.brs.2020.12.004eng
hcfmusp.relation.referencePondal Margarita, 2008, J Geriatr Phys Ther, V31, P57eng
hcfmusp.relation.referenceRIDER LG, ARTHRITIS CARE RES Heng
hcfmusp.relation.referenceRider LG, 2018, NAT REV RHEUMATOL, V14, P303, DOI 10.1038/nrrheum.2018.33eng
hcfmusp.relation.referenceRocha K, 2020, PHYSIOL BEHAV, V224, DOI 10.1016/j.physbeh.2020.113036eng
hcfmusp.relation.referenceSouza Fernando Henrique Carlos de, 2011, Rev Bras Reumatol, V51, P428eng
hcfmusp.relation.referenceStaud R, 2012, CURR RHEUMATOL REP, V14, P539, DOI 10.1007/s11926-012-0277-zeng
hcfmusp.relation.referenceTanaka S, 2011, NEUROREHAB NEURAL RE, V25, P565, DOI 10.1177/1545968311402091eng
hcfmusp.relation.referenceWorkman CD, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00420eng
relation.isAuthorOfPublication6e326b37-799e-4b16-890b-567d39dbe44c
relation.isAuthorOfPublication49ae43e6-bc9b-412a-98b0-9d1c27e07b0a
relation.isAuthorOfPublication129507a6-35dd-4bc5-b533-cc7bbc87d5dc
relation.isAuthorOfPublication5cafb5db-e92f-4732-b4d7-97076cc5f269
relation.isAuthorOfPublicationa8c8396f-99fd-4576-a93b-d0e0ddb7f126
relation.isAuthorOfPublication009b652e-47c8-4d0a-a135-37b5e5c3477a
relation.isAuthorOfPublication07f179c5-58d8-4efe-832c-52095a9009d6
relation.isAuthorOfPublication.latestForDiscovery6e326b37-799e-4b16-890b-567d39dbe44c
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_SOUSA_Transcranial_direct_current_stimulation_is_safe_and_effective_2023.PDF
Tamanho:
436.89 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)